Hijaking the SARS-CoV-2 Cytokinopathy: Janus Kinase Inhibitors for Moderate to Severe COVID-19
2021 ◽
pp. annrheumdis-2021-219919
Keyword(s):
Keyword(s):
Keyword(s):
2021 ◽
Vol 7
(2)
◽
pp. 85-91
2021 ◽
Vol 171
(2)
◽
pp. 170-174